OR2D2 Inhibitors
OR2D2 inhibitors encompass a range of compounds that can indirectly inhibit the functional activity of the OR2D2 protein, which is part of the olfactory receptor family of GPCRs. These inhibitors do not directly target OR2D2 but act through various mechanisms to affect the signaling pathways and cellular processes that OR2D2 is involved in. For instance, quinidine and lidocaine inhibit sodium channels, leading to reduced neuronal excitability, which is essential for the initiation of OR2D2-mediated signaling. Ketoconazole alters the lipid composition of cell membranes, potentially affecting the microenvironment necessary for proper OR2D2 function. Zinc ions and copper compounds, including copper sulfate and copper chloride, act as allosteric modulators of GPCRs, and their binding to OR2D2 can result in conformational changes that reduce the receptor's activity.
Additionally, clozapine's broad-spectrum antagonism of GPCRs, and chlorpromazine's blockade of dopamine and serotonin receptors, can lead to changes in cAMP levels, which are crucial for OR2D2 signaling. Verapamil and diltiazem, by inhibiting calcium channels, reduce calcium influx, thereby potentially affecting the phosphorylation and activity of OR2D2. Amiloride's inhibition of ENaC affects the ionic balance acrossthe olfactory epithelium, which could indirectly alter OR2D2 function due to changes in the excitability of olfactory sensory neurons. Propanolol, through its antagonistic effect on beta-adrenergic receptors, causes a reduction in cAMP levels, which may decrease the signaling efficacy of OR2D2.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quinidine | 56-54-2 | sc-212614 | 10 g | $104.00 | 3 | |
Quinidine is a voltage-gated sodium channel blocker that can lead to decreased excitability of neurons. Since OR2D2 is expressed in olfactory sensory neurons, quinidine can indirectly inhibit OR2D2 by reducing the neuronal activity required for OR2D2-mediated signal transduction. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
Ketoconazole interferes with cytochrome P450 enzymes, crucial for various cellular processes. This can lead to altered cell membrane compositions where OR2D2 is localized, affecting the receptor's environment and indirectly inhibiting its function. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc ions can act as allosteric modulators of G protein-coupled receptors (GPCRs). By binding to modulatory sites, Zn2+ can change the conformation of OR2D2, leading to decreased receptor activity. | ||||||
Copper(II) sulfate | 7758-98-7 | sc-211133 sc-211133A sc-211133B | 100 g 500 g 1 kg | $46.00 $122.00 $189.00 | 3 | |
Copper ions can also act as allosteric inhibitors of GPCRs. By interacting with OR2D2, copper sulfate can modify the receptor's structure and impair its ability to activate downstream signaling pathways. | ||||||
Lidocaine | 137-58-6 | sc-204056 sc-204056A | 50 mg 1 g | $51.00 $131.00 | ||
Lidocaine, as a sodium channel blocker, lowers the action potential firing rate of neurons. This can indirectly inhibit OR2D2 by reducing the synaptic release of neurotransmitters that might otherwise trigger OR2D2 signaling. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine is a known antagonist of several GPCRs. Although not a direct inhibitor of OR2D2, its broad-spectrum GPCR antagonism can lead to changes in GPCR signaling networks that indirectly downregulate OR2D2 activity. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine blocks dopamine and serotonin receptors, which can lead to reduced cAMP levels in cells. Since cAMP is involved in GPCR signaling, this can indirectly inhibit OR2D2 by reducing its signaling efficacy. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil blocks voltage-dependent L-type calcium channels, reducing calcium influx. Since intracellular calcium levels can modulate GPCR function, verapamil can indirectly inhibit OR2D2 by reducing calcium-dependent signaling. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride inhibits epithelial sodium channels (ENaC), potentially altering the ionic balance across the olfactory epithelium and indirectly affecting OR2D2 signaling due to changes in the neuronal excitability. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem inhibits calcium channels, and by reducing intracellular calcium, it can affect the phosphorylation state of GPCRs. This might lead to an indirect inhibition of OR2D2 signaling through decreased receptor activation. | ||||||